Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Parathyroid imaging with 99Tcm-tetrofosmin

A Giordano1, G Meduri, P Marozzi

  • 1Istituto di Medicina Nucleare, Università Cattolica del S. Cuore, Rome, Italy.

Nuclear Medicine Communications
|August 1, 1996
PubMed
Summary

Technetium-99m-tetrofosmin is a suitable agent for parathyroid scintigraphy, offering superior image quality compared to thallium-201. This agent aids in diagnosing hyperparathyroidism effectively.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Study of viral integration of HPV-16 in young patients with LSIL.

Journal of clinical pathology·2003
Same author

Interference of bovine herpesvirus 1 (BHV-1) in sorbitol-Induced apoptosis.

Journal of cellular biochemistry·2003
Same author

EGF-responsive rat neural stem cells: molecular follow-up of neuron and astrocyte differentiation in vitro.

Journal of cellular physiology·2003
Same author

Air pollution and respiratory pathology: lung cancer.

Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace·2003
Same author

Differences between 99mTc-sestamibi and 99mTc-tetrofosmin uptake in thyroid and salivary glands: comparison with 99mTc-pertechnetate in 86 subjects.

Nuclear medicine communications·2003
Same author

Burkitt's lymphoma: new insights into molecular pathogenesis.

Journal of clinical pathology·2003

Area of Science:

  • Nuclear Medicine
  • Radiopharmacology

Background:

  • Hyperparathyroidism diagnosis relies on accurate localization of abnormal parathyroid glands.
  • Traditional imaging agents have limitations in sensitivity and image quality.

Purpose of the Study:

  • To assess the efficacy of 99mTc-tetrofosmin for parathyroid scintigraphy.
  • To compare 99mTc-tetrofosmin with 201Tl for parathyroid imaging.

Main Methods:

  • Parathyroid scintigraphy was performed using 99mTc-tetrofosmin and 201Tl in 10 hyperparathyroid patients and 2 controls.
  • Thyroid imaging utilized 99mTc-pertechnetate for subtraction.
  • Scintigraphic findings were correlated with surgical outcomes.

Main Results:

  • Both agents showed 8 true positives, 1 false negative, and 1 false positive, with 80% concordance.

Related Experiment Videos

  • 99mTc-tetrofosmin provided superior image quality over 201Tl, even after thyroid subtraction.
  • Surgical findings confirmed seven parathyroid adenomas, two with co-existing thyroid adenomas, and one thyroid carcinoma.

    • Conclusions:

    • 99mTc-tetrofosmin is a suitable radiotracer for parathyroid scintigraphy.
    • Its diagnostic accuracy and favorable dosimetry support its use in clinical practice.